Evaluation Confirms: QIAGEN's New GeneReader NGS System Delivers Valuable Clinical Insights
Go back to Evaluation Confirms: QIAGEN's New GeneReader NGS System Delivers Valuable Clinical Insights| Qiagen NV (NYSE: QGEN) | Delayed: 42.50 +0.37 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.13 | 52 Week High | $28.50 | |||
| Open | $42.58 | 52 Week Low | $19.94 | |||
| Day High | $42.65 | P/E | 146.55 | |||
| Day Low | $42.02 | EPS | $0.29 | |||
| Volume | 1,107,756 | |||||
| (NYSE: QIA) | Delayed: 0.00 -10.35 (100%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.35 | 52 Week High | $ | |||
| Open | $10.35 | 52 Week Low | $ | |||
| Day High | $10.35 | P/E | N/A | |||
| Day Low | $10.35 | EPS | $ | |||
| Volume | 0 | |||||
